liquid biopsy

by Jawad Shabbir, Peking University edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: www.kaboompics.com from Pexels An innovative platform developed by PKU researchers called “cf-EpiTracing” has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood. The research, published in Nature on […]

by Johns Hopkins University School of Medicine edited by Stephanie Baum, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: CC0 Public Domain Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver

by Niigata University edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source A photo of lab members from the Department of Neurosurgery, Niigata University, including Dr. Masaki Mitobe (first row, far right) and Dr. Manabu Natsumeda (second row, third from left). Credit: Niigata University A group led by the Department of

by Vall d’Hebron Institute of Oncology edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes Credit: Unsplash/CC0 Public Domain Published today in Clinical Cancer Research, findings from a study led by investigators at the Vall d’Hebron Institute of Oncology (VHIO), which forms part of the Vall d’Hebron Campus, underscore the efficacy of analyzing circulating tumor DNA (ctDNA) using a